Mount Yale Investment Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,959
Closed -$301K 1104
2025
Q4
$301K Buy
+2,959
New +$238K 0.01% 596
2025
Q3
Sell
-425
Closed -$22.6K 975
2025
Q2
$22.6K Buy
+425
New +$21.6K ﹤0.01% 1020
2018
Q4
Sell
-23
Closed -$2K 464
2018
Q3
$2K Sell
23
-199
-90% -$13K ﹤0.01% 902
2018
Q2
$13K Sell
222
-1,034
-82% -$55.6K ﹤0.01% 856
2018
Q1
$51K Buy
+1,256
New +$61.3K 0.01% 613

Other funds holding EXAS

Mount Yale Investment Advisors's EXAS Position: Q1 2026 in Review

Mount Yale Investment Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 2,959 shares — an estimated $301K sold.

Mount Yale Investment Advisors first reported a position in EXAS in Q1 2018 and held it in 5 quarters. The position peaked at $301K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Mount Yale Investment Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Mount Yale Investment Advisors sold 2,959 Exact Sciences shares in Q1 2026, an estimated $301K.
  • Mount Yale Investment Advisors first reported a position in Exact Sciences in Q1 2018 and held it in 5 quarters.
  • Mount Yale Investment Advisors's Exact Sciences position peaked at $301K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Mount Yale Investment Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.